These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9085171)

  • 1. New endoscopic treatment for chronic pancreatitis, using contrast media containing ulinastatin and prednisolone.
    Ohwada M; Watanabe N; Maeda M; Gotoh M; Teramoto J; Moriya H; Nakajima T; Okamoto T; Tsuji N; Kobayashi D; Niitsu Y
    J Gastroenterol; 1997 Apr; 32(2):216-21. PubMed ID: 9085171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial.
    Yoo JW; Ryu JK; Lee SH; Woo SM; Park JK; Yoon WJ; Lee JK; Lee KH; Hwang JH; Kim YT; Yoon YB
    Pancreas; 2008 Nov; 37(4):366-70. PubMed ID: 18953247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized control study to investigate the application of Ulinastatin-containing contrast medium to prevent post-ERCP pancreatitis.
    Wang J; Su J; Lu Y; Zhou H; Gong B
    Hepatogastroenterology; 2014; 61(136):2391-4. PubMed ID: 25699389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study.
    Fujishiro H; Adachi K; Imaoka T; Hashimoto T; Kohge N; Moriyama N; Suetsugu H; Kawashima K; Komazawa Y; Ishimura N; Ishihara S; Amano Y; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1065-9. PubMed ID: 16724996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.
    Hauser G; Blažević I; Salkić N; Poropat G; Giljača V; Bulić Z; Štimac D
    Surg Endosc; 2017 Feb; 31(2):602-610. PubMed ID: 27317032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial.
    Ueki T; Otani K; Kawamoto K; Shimizu A; Fujimura N; Sakaguchi S; Matsui T
    J Gastroenterol; 2007 Feb; 42(2):161-7. PubMed ID: 17351806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between ulinastatin and nafamostat for prevention of post-endoscopic retrograde cholangiopancreatography complications: a prospective, randomized trial.
    Park JY; Jeon TJ; Hwang MW; Sinn DH; Oh TH; Shin WC; Choi WC
    Pancreatology; 2014; 14(4):263-7. PubMed ID: 25062874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: the Emperor's New Clothes or Aladdin's Magic Lamp?
    Chen S; Shi H; Zou X; Luo H
    Pancreas; 2010 Nov; 39(8):1231-7. PubMed ID: 20531245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.
    Devière J; Le Moine O; Van Laethem JL; Eisendrath P; Ghilain A; Severs N; Cohard M
    Gastroenterology; 2001 Feb; 120(2):498-505. PubMed ID: 11159890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
    Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
    Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography.
    Chan HH; Lai KH; Lin CK; Tsai WL; Lo GH; Hsu PI; Wei MC; Wang EM
    J Chin Med Assoc; 2008 Dec; 71(12):605-9. PubMed ID: 19114324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical study on the prevention of post-ERCP pancreatitis by pancreatic duct stenting.
    Pan XP; Dang T; Meng XM; Xue KC; Chang ZH; Zhang YP
    Cell Biochem Biophys; 2011 Dec; 61(3):473-9. PubMed ID: 21739262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of Raw Rhubarb Solution in the Precaution of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Patients with High-Risk Factors: A Predictive Random Compared Research in One Center.
    Wang C; Li Q; Ye P; Zeng S; Li GH; Chen YX; Zhou XJ; Lv NH
    Dig Dis Sci; 2017 Apr; 62(4):1043-1050. PubMed ID: 28194668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
    Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH
    Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of painless pancreatitis by computed tomography in patients with post-endoscopic retrograde cholangiopancreatography hyperamylasemia.
    Uchino R; Sasahira N; Isayama H; Tsujino T; Hirano K; Yagioka H; Hamada T; Takahara N; Miyabayashi K; Mizuno S; Mohri D; Sasaki T; Kogure H; Yamamoto N; Nakai Y; Tada M; Koike K
    Pancreatology; 2014; 14(1):17-20. PubMed ID: 24555974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography.
    Sand J; Nordback I
    Digestion; 1993; 54(2):105-11. PubMed ID: 8319838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6, IL-10 and TNFα do not improve early detection of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: a prospective cohort study.
    Concepción-Martín M; Gómez-Oliva C; Juanes A; Mora J; Vidal S; Díez X; Torras X; Sainz S; Villanueva C; Farré A; Guarner-Argente C; Guarner C
    Sci Rep; 2016 Sep; 6():33492. PubMed ID: 27642079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct spraying of shakuyakukanzoto onto the duodenal papilla: a novel method for preventing pancreatitis following endoscopic retrograde cholangiopancreatography.
    Fujinami H; Kajiura S; Ando T; Mihara H; Hosokawa A; Sugiyama T
    Digestion; 2015; 91(1):42-5. PubMed ID: 25632916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial.
    Uchino R; Isayama H; Tsujino T; Sasahira N; Ito Y; Matsubara S; Takahara N; Arizumi T; Toda N; Mohri D; Togawa O; Yagioka H; Yanagihara Y; Nakajima K; Akiyama D; Hamada T; Miyabayashi K; Mizuno S; Kawakubo K; Kogure H; Sasaki T; Yamamoto N; Nakai Y; Hirano K; Tada M; Koike K
    Gastrointest Endosc; 2013 Dec; 78(6):842-850. PubMed ID: 23910063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.